Glioblastoma trials in South Korea

In South Korea 7 Also abroad 424

7 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in South Korea
Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma
Where
Busan, Seongnam-si, Seoul
Age
19 years to 69 years
People
60
Run by
Dong-A University Hospital
See details and how to joinNCT07831161
Phase 1/2Taking people
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Where
Seoul
Age
Up to 25 years
People
75 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00
Phase 1Taking people
A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma
Where
Seongnam
Age
19 years to 70 years
People
10
Run by
CHA University
See details and how to joinNCT07143812
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma
Where
Incheon, Seongnam-si, Seoul
Age
18 years and over
People
43
Run by
Rznomics, Inc.
See details and how to joinNCT06102525
Phase 3Taking people
Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
Where
Seoul
Age
70 years and over
People
178
Run by
Severance Hospital
See details and how to joinNCT05439278
Phase 1Taking people
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
Where
Seoul
Age
19 years and over
People
12
Run by
BeyondBio Inc.
See details and how to joinNCT05769660
No phaseTaking people
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Where
Daejeon
People
150
Run by
Chungnam National University Hospital
See details and how to joinNCT06782984